|
Congestive
Citations 391-400 of 1406 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Association of Cystatin C With Mortality, Cardiovascular Events, and Incident Heart Failure Among Persons With Coronary Heart Disease. Data From the Heart and Soul Study
- Joachim H. Ix, Michael G. Shlipak, Glenn M. Chertow, and Mary A. Whooley
Circulation published December 26, 2006, doi:10.1161/CIRCULATIONAHA.106.644286
[Abstract]
- Articles
Hemodynamic Modulation of Endocardial Thromboresistance
- Navin K. Kapur, Clayton B. Deming, Sunil Kapur, Ce Bian, Hunter C. Champion, J. Kevin Donahue, David A. Kass, and Jeffrey J. Rade
Circulation published December 26, 2006, doi:10.1161/CIRCULATIONAHA.106.640698
[Abstract]
- Articles
Inducible Cardiac-Restricted Expression of Enteroviral Protease 2A Is Sufficient to Induce Dilated Cardiomyopathy
- Dingding Xiong, Toshitaka Yajima, Byung-Kwan Lim, Antine Stenbit, Andrew Dublin, Nancy D. Dalton, Daphne Summers-Torres, Jeffery D. Molkentin, Herve Duplain, Rainer Wessely, Ju Chen, and Kirk U. Knowlton
Circulation published December 26, 2006, doi:10.1161/CIRCULATIONAHA.106.631093
[Abstract]
- Articles
Effects of Cardiac Resynchronization Therapy With or Without a Defibrillator on Survival and Hospitalizations in Patients with New York Heart Association Class IV Heart Failure
- JoAnn Lindenfeld, Arthur M. Feldman, Leslie Saxon, John Boehmer, Peter Carson, Jalal K. Ghali, Inder Anand, Steve Singh, Jonathan S. Steinberg, Brian Jaski, Teresa DeMarco, David Mann, Patrick Yong, Elizabeth Galle, Fred Ecklund, and Michael Bristow
Circulation published December 26, 2006, doi:10.1161/CIRCULATIONAHA.106.629261
[Abstract]
- Special Reports
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
- Victor J. Dzau, Elliott M. Antman, Henry R. Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, and William Stevenson
Circulation 2006;114:2850-2870, doi:10.1161/CIRCULATIONAHA.106.655688
[Full text]
- Special Reports
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part II: Clinical Trial Evidence (Acute Coronary Syndromes Through Renal Disease) and Future Directions
- Victor J. Dzau, Elliott M. Antman, Henry R. Black, David L. Hayes, JoAnn E. Manson, Jorge Plutzky, Jeffrey J. Popma, and William Stevenson
Circulation 2006;114:2871-2891, doi:10.1161/CIRCULATIONAHA.106.655761
[Full text]
- Articles
Prospective Familial Assessment in Dilated Cardiomyopathy. Cardiac Autoantibodies Predict Disease Development in Asymptomatic Relatives
- Alida L.P. Caforio, Niall G. Mahon, M. Kamran Baig, Francesco Tona, Ross T. Murphy, Perry M. Elliott, and William J. McKenna
Circulation published December 18, 2006, doi:10.1161/CIRCULATIONAHA.106.641472
[Abstract]
- Articles
Sildenafil Improves Exercise Hemodynamics and Oxygen Uptake in Patients With Systolic Heart Failure
- Gregory D. Lewis, Justine Lachmann, Janice Camuso, John J. Lepore, Jordan Shin, Maryann E. Martinovic, David M. Systrom, Kenneth D. Bloch, and Marc J. Semigran
Circulation published December 18, 2006, doi:10.1161/CIRCULATIONAHA.106.626226
[Abstract]
- Editorials
Aldosterone and Cardiovascular Disease: Smoke and Fire
- David A. Calhoun
Circulation 2006;114:2572-2574, doi:10.1161/CIRCULATIONAHA.106.668715
[Full text]
- Pediatric Cardiology
Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study
- Piers E. F. Daubeney, Alan W. Nugent, Patty Chondros, John B. Carlin, Steven D. Colan, Michael Cheung, Andrew M. Davis, C.W. Chow, Robert G. Weintraub on behalf of the National Australian Childhood Cardiomyopathy Study
Circulation 2006;114:2671-2678; published online before print as doi:10.1161/CIRCULATIONAHA.106.635128
[Abstract]
[Full text]
|
|
